TROGARZO (ibalizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** IBALIZUMAB

**Strength:** 150 mg/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Theratechnologies Inc.

**Marketing category:** BLA (BLA761065)

**Pharmacologic class:** Antibodies, Monoclonal, Humanized [CS], CD4-directed Antibody Interactions [MoA], CD4-directed Blocking Antibody [EPC], HIV 1 Post-attachment Fusion Inhibitors [MoA], Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]